| Product Code: ETC9972634 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) PCR-based Infectious Diseases Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) PCR-based Infectious Diseases Market - Industry Life Cycle |
3.4 United States (US) PCR-based Infectious Diseases Market - Porter's Five Forces |
3.5 United States (US) PCR-based Infectious Diseases Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 United States (US) PCR-based Infectious Diseases Market Revenues & Volume Share, By Infection, 2021 & 2031F |
3.7 United States (US) PCR-based Infectious Diseases Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.8 United States (US) PCR-based Infectious Diseases Market Revenues & Volume Share, By PCR Technology, 2021 & 2031F |
3.9 United States (US) PCR-based Infectious Diseases Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.10 United States (US) PCR-based Infectious Diseases Market Revenues & Volume Share, By Testing, 2021 & 2031F |
3.11 United States (US) PCR-based Infectious Diseases Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) PCR-based Infectious Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in the US |
4.2.2 Technological advancements in PCR-based testing methods |
4.2.3 Growing demand for accurate and rapid diagnostic solutions in healthcare |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of PCR-based infectious disease tests |
4.3.2 High cost associated with PCR-based testing procedures |
4.3.3 Limited accessibility to PCR-based diagnostic facilities in certain regions of the US |
5 United States (US) PCR-based Infectious Diseases Market Trends |
6 United States (US) PCR-based Infectious Diseases Market, By Types |
6.1 United States (US) PCR-based Infectious Diseases Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Tuberculosis PCR Test, 2021- 2031F |
6.1.4 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Hepatitis PCR Test, 2021- 2031F |
6.1.5 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Human Immunodeficiency Virus (HIV) PCR Test, 2021- 2031F |
6.1.6 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Influenza PCR Test, 2021- 2031F |
6.1.7 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Human Papilloma Virus (HPV) PCR Test, 2021- 2031F |
6.2 United States (US) PCR-based Infectious Diseases Market, By Infection |
6.2.1 Overview and Analysis |
6.2.2 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Viral Infection, 2021- 2031F |
6.2.3 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Respiratory Tract Infection, 2021- 2031F |
6.2.4 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Sexually Transmitted Infection, 2021- 2031F |
6.2.5 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Hospital Acquired Infections, 2021- 2031F |
6.2.6 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Other Infections, 2021- 2031F |
6.3 United States (US) PCR-based Infectious Diseases Market, By Pathogen |
6.3.1 Overview and Analysis |
6.3.2 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Viral, 2021- 2031F |
6.3.3 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Bacterial, 2021- 2031F |
6.3.4 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Fungal, 2021- 2031F |
6.3.5 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Protozoa, 2021- 2031F |
6.3.6 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) PCR-based Infectious Diseases Market, By PCR Technology |
6.4.1 Overview and Analysis |
6.4.2 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By RT PCR, 2021- 2031F |
6.4.3 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Multiplex PCR, 2021- 2031F |
6.4.4 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) PCR-based Infectious Diseases Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5.4 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Adults, 2021- 2031F |
6.6 United States (US) PCR-based Infectious Diseases Market, By Testing |
6.6.1 Overview and Analysis |
6.6.2 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Laboratory Based Testing, 2021- 2031F |
6.6.3 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Point of Care Testing, 2021- 2031F |
6.7 United States (US) PCR-based Infectious Diseases Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.3 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.5 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.6 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Clinics, 2021- 2031F |
6.7.7 United States (US) PCR-based Infectious Diseases Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 United States (US) PCR-based Infectious Diseases Market Import-Export Trade Statistics |
7.1 United States (US) PCR-based Infectious Diseases Market Export to Major Countries |
7.2 United States (US) PCR-based Infectious Diseases Market Imports from Major Countries |
8 United States (US) PCR-based Infectious Diseases Market Key Performance Indicators |
8.1 Adoption rate of PCR-based infectious disease testing in healthcare facilities |
8.2 Number of research and development activities focused on enhancing PCR-based testing technologies |
8.3 Percentage of healthcare professionals trained in utilizing PCR-based diagnostic tools |
9 United States (US) PCR-based Infectious Diseases Market - Opportunity Assessment |
9.1 United States (US) PCR-based Infectious Diseases Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 United States (US) PCR-based Infectious Diseases Market Opportunity Assessment, By Infection, 2021 & 2031F |
9.3 United States (US) PCR-based Infectious Diseases Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.4 United States (US) PCR-based Infectious Diseases Market Opportunity Assessment, By PCR Technology, 2021 & 2031F |
9.5 United States (US) PCR-based Infectious Diseases Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.6 United States (US) PCR-based Infectious Diseases Market Opportunity Assessment, By Testing, 2021 & 2031F |
9.7 United States (US) PCR-based Infectious Diseases Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) PCR-based Infectious Diseases Market - Competitive Landscape |
10.1 United States (US) PCR-based Infectious Diseases Market Revenue Share, By Companies, 2024 |
10.2 United States (US) PCR-based Infectious Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here